Schrödinger Virtual User Group Meeting 2020


Overview
Join us this fall for Schrödinger's Virtual UGM 2020. This live event will feature presentations, Q&As, and discussion forums over a number of weeks from the Schrödinger user community. This event is free but registration is required, we'll see you online!

Recordings
To view the available recordings from the Materials Science Stream, please click here.
To view the available recordings from the Drug Discovery Stream, please click here.

Please note: A schrodinger.com web account will be required to access the recordings - request web account.

Agenda
A wide range of computational chemistry topics will be covered including materials, drug discovery, medicinal chemistry, and biologics. Please click on the stream tabs, at the top of the page,  for detailed agendas.

Stream: Dates: Time:
Materials Science October 27th
October 29th
 1:00 PM ET / 10:00 AM PT
10:00 AM ET / 7:00 AM PT
Drug Discovery November 12th
November 19th
December 3rd
 1:00 PM ET / 10:00 AM PT
1:00 PM ET / 10:00 AM PT
1:00 PM ET / 10:00 AM PT


Overview
Schrödinger's Virtual UGM 2020 features live presentations on a wide range of topics from the Schrödinger user community, including Q&A sessions and discussion forums. Our materials science stream features presentations on projects in industry and academia on a variety of topics of interest to materials science researchers and engineers. This event is free, but registration is required, we'll see you online!

Recordings
To view the recordings for any of the sessions, please click here.

Please note: A schrodinger.com web account will be required to access the recordings - request web account.

Agenda

Stream 1 - Materials Science

DateTimeTopic or TitlePresenter
October 271:00 PM ETWelcome 
October 271:05 PM ETComputational explorations on a vast chemical space of electroactive compounds for energy storageProfessor Süleyman Er, Differ
Dutch Institute for Fundamental Energy Research
October 271:50 PM ETMolecular Modeling of Polycyanurates to Predict Thermophysical Properties
(View Recording)
Dr. Levi Moore, US Air Force
Air Force Research Laboratory
Aerospace Systems Directorate, Edwards AFB
October 272:30 PM ETMolecular Dynamics to Understand the Origin of the Preferred Orientation of Phosphorescent Dyes in OLEDs
(View Recording)
Dr. Changki Moon
School of Physics & Astronomy
University of St. Andrews
 
    
October 2910:00 AM ETWelcome 
October 2910:05 AM ETMaterials Design in Electronics Industry: Application of Materials Informatics and Cloud Computing Environment to the Design of Organic Carrier Transport Materials
(View Recording)
Dr. Nobuyuki N. Matsuzawa
Engineering Division, Industrial Solutions Company
Panasonic Corporation
October 2910:50 AM ETModeling and Characterization of Recyclable Telechelic 1,3-Enchained Oligocyclobutanes: Density Functional Theory, Transition State Theory, and Molecular Dynamics Simulations
(View Recording)
Dr. Jarod M. Younker
ExxonMobil Chemical Company
October 2911:30 AM ETSchrödinger-hosted Discussion Forum
(View Recording)
Dr. Simon D. Elliott
Director, Atomic Level Process Simulation 
Schrödinger

 

Overview
Schrödinger's Virtual UGM 2020 features live presentations on a wide range of topics from the Schrödinger user community, including Q&A sessions and discussion forums. Our drug discovery stream features presentations on projects in industry and academia on a variety of topics on computational chemistry, medicinal chemistry, biologics design, and more. This event is free, but registration is required, we'll see you online!

Recordings
To view the recordings for any of the sessions, please click here.

Please note: A schrodinger.com web account will be required to access the recordings - request web account.

Agenda

Drug Discovery Stream

Small-Molecule Drug Discovery
DateTimeTopic or TitlePresenter
November 121:00 PM ETWelcomeMatt Repasky, Ph.D., VP, Life Sciences Products, Schrödinger
November 121:05 PM ETRecent Advances to Increase Impact of Simulation on the Drug Discovery Process
(View Recording)
Matt Repasky, Ph.D., VP, Life Sciences Products, Schrödinger
Erin Davis, Ph.D., VP, Enterprise Informatics, Schrödinger
November 121:50 PM ETUsing CryoEM, X-Ray Crystallography and Laboratory Evolution to Design Synthetic Group A Streptogramin Antibiotics that Overcome Vat Resistance
(View Recording)
Professor James Fraser, Ph.D., Department of Bioengineering
and Therapeutic Sciences
California Institute of Quantitative Biosciences
November 122:30 PM ETIFD/WScore/CryoEM
(View Recording)
Professor Richard A. Friesner, Ph.D., Columbia University
Director of the Columbia Center for Biomolecular Simulation
November 123:10 PM ETUltra-Large Library Docking for New Chemotypes with New Pharmacology
(View Recording)
Professor Brian K. Shoichet, Ph.D., UC San Francisco
November 123:40 PM ETSchrödinger-hosted
Discussion
(View Recording)
 
Medicinal Chemistry
DateTimeTopic or TitlePresenter
November 191:00 PM ETWelcomeAleksey Gerasyuto, Ph.D., Executive Director, Schrödinger
November 191:05 PM ETSolubility FEP+Kevin P. Cusack, Ph.D., Research Fellow, ACOS, AbbVie
November 191:50 PM ETTarget-based Drug Discovery in TB (tuberculosis) Research
(View Recording)
Nader Fotouhi, Ph.D., Chief Scientific Officer, TB Alliance
November 192:30 PM ETFragment-Based Approaches for αV Integrin AntagonistsJames Dowling, Ph.D., Associate Director, Medicinal Chemistry,
Morphic Therapeutic
November 193:10 PM ETApplication of FEP+ and Protein FEP+ to Rapid Discovery and Optimization of Potent and Selective Kinase Inhibitors
(View Recording)
Aleksey Gerasyuto, Ph.D., Executive Director, Schrödinger
November 193:40 PM ETSchrödinger-hosted
Discussion
(View Recording)
 
Biologics
DateTimeTopic or TitlePresenter
December 031:00 PM ETWelcomeHubert Li, Ph.D., Senior Scientist, Schrödinger
December 031:05 PM ETAntibody Humanization Guided by Computational Modeling
(View Recording)
Eliud Oloo, Ph.D., Senior Principal Scientist, Schrödinger
December 031:50 PM ETOff-target Selectivity of pMHC Targeting Chimeric Antigen ReceptorsDora Toledo Warshaviak, Ph.D., Senior Scientist,
A2 Biotherapeutics
December 032:30 PM ETFEP+ for Biologics
(View Recording)
Guido Scarabelli, Ph.D., Senior Scientist I, Schrödinger
December 033:10 PM ETImproving the Drug-like Properties of Affinity-Matured Antibodies via QSPRChristopher Negron, Ph.D., Senior Scientist II, AbbVie
December 033:50 PM ETSchrödinger-hosted
Discussion
(View Recording)
 

 


 

Back To Top